Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CLDXCelldex Therapeutics Inc
| 0% | $20.271M 547,707 shares@ $37.01 avg price | Exited |
ROIVRoivant Sciences Ltd
| 0% | $19.749M 1.868M shares@ $10.58 avg price | Exited |
MDGLMadrigal Pharmaceuticals Inc
| 0% | $12.444M 44,417 shares@ $280.17 avg price | Exited |
PODDInsulet Corp
| 0% | $12.303M 60,967 shares@ $201.81 avg price | Exited |
AXNXAxonics Inc
| 0% | $10.117M 150,490 shares@ $67.24 avg price | Exited |
PEPGPepgen Inc
| 0% | $8.956M 561,128 shares@ $15.97 avg price | Exited |
DXCMDexcom Inc
| 0% | $6.972M 61,494 shares@ $113.39 avg price | Exited |
WATWaters Corp
| 0% | $6.326M 21,804 shares@ $290.12 avg price | Exited |
FDMT4d Molecular Therapeutics Inc
| 0% | $5.692M 271,155 shares@ $20.99 avg price | Exited |
BAXBaxter Intl Inc
| 0% | $3.939M 117,769 shares@ $33.45 avg price | Exited |